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False-Positive Hypermetabolic Lesions on Post-Treatment 
PET-CT after Influenza Vaccination
Jeong-Eun Kim, Eun Kyoung Kim, Dae Ho Lee, Sang-We Kim, Cheolwon Suh, and Jung-Shin Lee
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
We report a case of a 59-year-old man with testicular germ cell tumor who showed new hypermetabolic lesions 
at the left axillary lymph nodes on a post-treatment positron emission tomography-computed tomography (PET-CT) 
scan. The hypermetabolic lesions were found to be caused by an influenza vaccination 10 days prior to the PET-CT 
scan and disappeared without additional treatment. To date, he is alive with complete remission. (Korean J Intern 
Med 2011;26:210-212) 
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INTRODUCTION
Serum tumor markers and computed tomography (CT) 
are primarily used for patients with germ cell tumors to 
evaluate efficacy of therapy, residual disease, or disease 
progression. Additionally, 18F-fluoro-deoxyglucose 
(
18F-FDG)-positron emission tomography (PET), which 
measures glucose metabolism, can provide the advantage 
of identifying and predicting the viability of residual 
tumors, which cannot be readily differentiated from non-
viable tissue, such as necrotic or fibrotic tissue, in CT 
scans [1,2]. Here, we report a case showing false-positive 
hypermetabolic lesions caused by an influenza vaccination 
during evaluation of a post-chemotherapy PET-CT scan.
CASE REPORT
A 59-year-old man presented with a mediastinal 
mass on a chest roentgenogram. Chest CT demonstrated 
enlarged right hilar and paratracheal lymph nodes, 
which were hypermetabolic on whole body 
18F-FDG 
PET-CT (Fig. 1). However, the PET-CT scan showed no 
other hypermetabolic lesion. Bronchoscopy revealed 
only extrinsic compression of the right bronchus with no 
endobronchial lesion. Thus, video-assisted thoracic surgery 
was performed for a biopsy of the paratracheal lymph 
nodes. The histology was consistent with seminoma, 
which was supported by immunostaining results: 
cytokeratin (+), placental alkaline phosphatase (+), alpha-
fetoprotein (aFP) (-), beta-human choriogonadotropin 
(b-hCG) (-), leukocyte common antigen (-), and CD30 (-). 
Ultrasound of the testicles showed microlithiasis in the 
right testis and serum aFP and b-hCG were in the normal 
range. After being diagnosed with burned-out testicular 
seminoma with multiple mediastinal and hilar lymph 
node metastases, he received four cycles of chemotherapy, 
consisting of ifosfamide, cisplatin, and etoposide. After 
completion of chemotherapy, he underwent whole-body 
PET-CT to evaluate the response and residual masses. In 
the PET-CT scan, hypermetabolic lesions in right hilar 
and paratracheal lymph nodes disappeared, while new 
multiple hypermetabolic lesions appeared in enlarged 
left axillary lymph nodes (Fig. 2). In-depth questioning 
of the patient revealed that he received an influenza 
vaccination 10 days prior to the PET-CT scan in his left 
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deltoid muscle, an area that drains to the left axillary 
lymph node chain, at a primary care office. We decided 
to perform a chest CT 3 weeks thereafter and the result 
revealed no lymphadenopathy in the left axillary area 
and no initial metastatic lymphadenopathy (Fig. 3). Since 
undergoing planned left radical orchiectomy, which 
showed microcalcification without evidence of the tumor, 
he is now being followed up regularly with no evidence of 
recurrence.
DISCUSSION
The identification of viable tumor cells after systemic 
chemotherapy is very important in the management 
Figure 1. Chest computed tomography (CT) and positron emission tomography (PET) before treatment. Chest CT shows enlarged 
right hilar and paratracheal lymph nodes (A, solid arrow), which are hypermetabolic on 18F-fluoro-deoxyglucose-PET scans (B, empty 
arrow).
Figure 2. Chest computed tomography (CT) and positron emission tomography (PET) after treatment. Chest CT and PET scans show 
disappearance of previous lesions, but new appearance of hypermetabolic enlarged axillary lymph nodes (A, solid arrow; B, empty ar-
row).
Figure 3. Chest computed tomography 4 weeks after surveillance. 
Axillary lymphadenopathy disappeared (solid arrow).
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of testicular cancer to avoid both unnecessary surgical 
exploration and additional unnecessary chemotherapy 
or radiotherapy, which can increase short-term and 
long-term toxicities. However, after tumor markers, 
such as aFP and b-hCG, are found to be in the normal 
range, approximately 25-30% of patients with germ cell 
tumors will still be left with a residual mass, for which 
conventional imaging modalities—such as a CT scan—
cannot differentiate viable tumors from fibrotic or 
necrotic tissue [1]. PET or PET-CT is useful in identifying 
the presence of viable tumors in post-treatment residual 
tumors with higher sensitivities and specificities than 
CT [2].
 However, as with all modalities, PET or PET-CT 
has some limitations. False-negative results can occur 
with the presence of a mature teratoma or a very small 
tumor, or if early scans are performed within 10-14 days 
from commencement of chemotherapy [3-5]. Conversely, 
false-positive results can be found with the presence of 
inflammatory changes or infection [6,7]. Importantly, the 
recognition of a false-positive result is very important 
to avoid unnecessary surgical resection or other toxic 
treatment. Our patient showed very favorable radiologic 
and metabolic responses to chemotherapy, but also the 
new appearance of hypermetabolic lesions in an unusual 
site. Fortunately, careful history documentation revealed 
the vaccination before PET scanning, which might have 
caused inflammation, with local lymphocyte activation 
and proliferation for antigen processing. Additionally, we 
showed spontaneous regression using CT after a 3-week 
observation period. However, no definite time-course of 
node activation was confirmed. Waiting at least 4 weeks 
after vaccination could minimize false-positives from 
vaccine immunity to tumor involvement of lymph nodes 
[8].
In summary, we report the case of a man with testicular 
germ cell tumor whose response to treatment was 
complicated by false-positive findings on a PET-CT scan 
caused by vaccination or inflammation. Recently, although 
PET or PET-CT studies are widely used to predict the 
response to treatment in germ cell tumors as well as in 
lymphoma or lung cancer, precautions must be taken when 
interpreting the results of PET-CT scans, particularly 
when they are not clinically correlated.
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